DEALS & CORPORATE GOVERNANCE
A $34 Billion Medical-Device Deal Collapsed Over One Question: Who Would Run It?
Advanced negotiations to combine Johnson & Johnson’s orthopaedics business with British medical-device group Smith & Nephew collapsed despite broad agreement on the financial structure of the transaction.
The proposed reverse merger would have created a company worth roughly $34 billion. But talks broke down after the two sides failed to agree on who should serve as chief executive.
THE BREAKDOWN
Johnson & Johnson wanted Namal Nawana, head of its orthopaedics business, to run the combined group. Smith & Nephew insisted that its existing chief executive, Deepak Nath, remain in charge.
DEAL CHECK
Combined value: ~$34B | Structure: reverse merger | Status: talks collapsed
Financial terms and much of the deal structure had already been agreed, according to the Financial Times, and the companies had been targeting a mid-October announcement before negotiations failed.
GOVERNANCE SIGNAL
Large mergers are often presented as exercises in valuation and strategic fit. In practice, control over management, compensation and corporate culture can be just as decisive as the financial model.
THE LONG VIEW
The failed transaction is a reminder that corporate consolidation does not depend only on whether the numbers work. Leadership control can destroy a multibillion-dollar agreement even after most of the economic terms are settled.
Geen opmerkingen:
Een reactie posten